Understanding Immunity to the COVID-19 Vaccines
1 other identifier
observational
43
1 country
1
Brief Summary
The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 9, 2020
CompletedFirst Posted
Study publicly available on registry
December 11, 2020
CompletedStudy Start
First participant enrolled
March 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2022
CompletedFebruary 28, 2022
February 1, 2022
10 months
December 9, 2020
February 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Percentage of participants with immunity to COVID-19 vaccines over time
1 year
Study Arms (1)
Participants
Adults who are receiving a COVID-19 vaccine
Interventions
Eligibility Criteria
Adults (18 years and older) receiving a COVID-19 vaccine
You may qualify if:
- Adults who are receiving a COVID-19 vaccine
You may not qualify if:
- Patients with special risks attendant to venipuncture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Stanford University, Hospital, and Clinics
Stanford, California, 94305, United States
Biospecimen
Blood samples, saliva, nasal swabs
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kari Nadeau, MD, PhD
Stanford University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
December 9, 2020
First Posted
December 11, 2020
Study Start
March 26, 2021
Primary Completion
January 6, 2022
Study Completion
January 6, 2022
Last Updated
February 28, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share